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Abstract
Recent evidence suggests that transient receptor potential melastatin 2 (TRPM2) expressed in immune cells plays an
important role in immune and inflammatory responses. We recently reported that TRPM2 expressed in macrophages and
spinal microglia contributes to the pathogenesis of inflammatory and neuropathic pain aggravating peripheral and central
pronociceptive inflammatory responses in mice. To further elucidate the contribution of TRPM2 expressed by peripheral
immune cells to neuropathic pain, we examined the development of peripheral nerve injury-induced neuropathic pain and
the infiltration of immune cells (particularly macrophages) into the injured nerve and spinal cord by using bone marrow
(BM) chimeric mice by crossing wildtype (WT) and TRPM2-knockout (TRPM2-KO) mice. Four types of BM chimeric mice were
prepared, in which irradiated WT or TRPM2-KO recipient mice were transplanted with either WT-or TRPM2-KO donor mouse-
derived green fluorescence protein-positive (GFP+) BM cells (TRPM2BM+/Rec+, TRPM2BM–/Rec+, TRPM2BM+/Rec–, and TRPM2BM–/
Rec– mice). Mechanical allodynia induced by partial sciatic nerve ligation observed in TRPM2BM+/Rec+ mice was attenuated in
TRPM2BM–/Rec+, TRPM2BM+/Rec–, and TRPM2BM–/Rec– mice. The numbers of GFP+ BM-derived cells and Iba1/GFP double-
positive macrophages in the injured sciatic nerve did not differ among chimeric mice 14 days after the nerve injury. In the
spinal cord, the number of GFP+ BM-derived cells, particularly GFP/Iba1 double-positive macrophages, was significantly
decreased in the three TRPM2-KO chimeric mouse groups compared with TRPM2BM+/Rec+ mice. However, the numbers of
GFP–/Iba1+ resident microglia did not differ among chimeric mice. These results suggest that TRPM2 plays an important role
in the infiltration of peripheral immune cells, particularly macrophages, into the spinal cord, rather than the infiltration of
peripheral immune cells into the injured nerves and activation of spinal-resident microglia. The spinal infiltration of
macrophages mediated by TRPM2 may contribute to the pathogenesis of neuropathic pain.
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Introduction
Neuropathic pain is a pathological pain condition that often
results from peripheral nerve injury. Several lines of evidence
suggest that neuroinflammation mediated by the interaction
between immune cells and neurons plays an important role in
neuropathic pain [1,2]. In response to peripheral nerve injury,
peripheral immune cells, such as macrophages, neutrophils, T-
lymphocytes and mast cells, infiltrate into the injured nerve and
become activated. Pronociceptive inflammatory mediators re-
leased from the activated immune cells can induce the sensitization
of nociceptors and increase the excitability of nociceptive primary
afferent neurons (peripheral sensitization). In the spinal cord, glial
cells such as microglia and astrocytes receive signals from the
injured peripheral neurons and become activated, which cause the
generation of synaptic facilitation and enhanced responsiveness of
nociceptive dorsal horn neurons (central sensitization) [3].
Additionally, there is increasing evidence that peripheral nerve
injury induces the infiltration of peripheral immune cells into the
spinal cord, which contributes to the pathogenesis of neuropathic
pain [4–8], although the details and mechanisms still remain
unclear.
Transient receptor potential melastatin 2 (TRPM2), a nonse-
lective cation channel, acts as a sensor for reactive oxygen species
(ROS) [9,10]. TRPM2 is highly expressed in the brain and
broadly in other tissues [11,12], but is also expressed abundantly in
immune cells, including monocytes/macrophages, neutrophils, T-
lymphocytes and microglia [13–15]. Recent studies have focused
extensively on the roles of TRPM2 expressed in immune cells.
TRPM2-mediated Ca2+ influx in monocytes induces the produc-
tion of proinflammatory cytokines/chemokines and the infiltration
of neutrophils, which contribute to the exacerbation of inflamma-
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tion [16–18]. TRPM2 expressed in T-lymphocytes contributes to
the cell proliferation and the production/release of proinflamma-
tory cytokines [19,20]. In dendritic cells, TRPM2 acts a lysosomal
Ca2+-release channel that promotes chemokine responsiveness and
cell migration [21]. By contrast, TRPM2-knockout (TRPM2-KO)
mice are susceptible to bacterial infection due to impaired
inflammatory responses and uncontrolled bacterial growth [22].
In this context, TRPM2 in phagocytic cells prevents nicotinamide
adenine dinucleotide phosphate oxidase-derived ROS production
through depolarization of the plasma membrane and thereby
protects against inflammation and tissue injury [23]. Taken
together, these findings suggest that TRPM2 expressed in immune
cells plays a critical role in immune and inflammatory responses.
Recently, we reported that TRPM2 expressed in macrophages
and spinal microglia contributes to the pathogenesis of inflamma-
tory and neuropathic pain through the aggravation of peripheral
and central pronociceptive inflammatory responses in mice [24].
However, previous experiments using TRPM2-KO mice did not
determine whether TRPM2 expressed in peripheral immune cells
or spinal microglia is more relevant to neuropathic pain. The
present study further explored the role of TRPM2 expressed in
peripheral immune cells in neuropathic pain by generating bone
marrow (BM) chimeric mice by crossing wildtype (WT) and
TRPM2-KO mice with green fluorescence protein-positive (GFP+)
BM transplantation. We then examined the development of
peripheral nerve injury-induced neuropathic pain, and observed
Iba1-positive (Iba1+) macrophages/microglia and GFP+ BM-
derived cells in the injured sciatic nerve and spinal cord.
Materials and Methods
Animals
This study was carried out in strict accordance with the
recommendations in the Guiding Principles for the Care and Use
of The Japanese Pharmacological Society. The protocol was
approved by the Kyoto University Animal Research Committee
(Permit Number: 2012–24 and 2013–24). All efforts were made to
minimize the number of animals used and to limit experimenta-
tion to that necessary to produce reliable scientific information.
TRPM2-KO mice were generated as previously reported [16].
The TRPM2-KO mouse line was backcrossed with C57BL/6J
mice for ten generations to eliminate any background effects on
the phenotype. C57BL/6-Tg(CAG-EGFP)C14–Y01-FM131Osb
transgenic mice (GFP-transgenic mice), a transgenic line with an
EGFP cDNA under the control of a chicken b-actin promoter and
cytomegalovirus enhancer [25], and C57BL/6J mice were
purchased from Nihon SLC (Shizuoka, Japan). All animals were
group-housed with free access to food and water and maintained
on a 12-h light/dark cycle.
Generation of BM Chimeric Mice
Homozygous TRPM22/2male mice were crossed with GFP-
transgenic female mice to produce GFP+ TRPM2+/2mice. GFP+
TRPM2+/+ (WT) mice and GFP+ TRPM22/2 (TRPM2-KO)
mice were obtained by the hetero-mating of GFP+ TRPM2+/
2female and male mice to obtain suitable BM donor mice. BM
transplantation was carried out as previously reported [26] with
slight modifications. BM recipients were male 6-week-old C57BL/
6J or TRPM2-KO mice. Recipient mice were lethally irradiated
with 10 Gy total body irradiation for 10 min. GFP+ WT or
TRPM2-KO donor mice were euthanized by decapitation, their
femurs were isolated, and both ends were cut and placed into a
microtube. The femurs were centrifuged at 2000 rpm for 10 min,
and the pellet of GFP+ BM cells was suspended in sterile
phosphate-buffered saline (PBS). Between 3–5 h after the irradi-
ation, the WT or TRPM2-KO recipient mice were transplanted
with 4.06106 BM cells by an intravenous injection into the tail
vein. WT recipient mice transplanted with WT donor mouse-
derived GFP+ BM cells (TRPM2BM+/Rec+), WT recipient mice
transplanted with TRPM2-KO donor mouse-derived GFP+ BM
cells (TRPM2BM–/Rec+), TRPM2-KO recipient mice transplanted
with WT donor mouse-derived GFP+ BM cells (TRPM2BM+/Rec–),
and TRPM2-KO recipient mice transplanted with TRPM2-KO
donor mouse-derived GFP+ BM cells (TRPM2BM–/Rec–) were
housed in an environment of specific pathogen-free conditions
with free access to autoclaved pellets and kanamycin-containing
autoclaved water (1:10,000). After 6 weeks, all chimeric animals
were housed in a conventional environment, and male BM
chimeric mice were used for pSNL surgery at the age of 12 weeks.
Flow Cytometry
Flow cytometry was used to identify the purity of GFP+ cells in
the blood after the BM transplantation. Peripheral blood (100 ml)
was collected from the tail vein of each chimeric mouse at 6 weeks
after BM transplantation. Collected blood was dissolved in 300 ml
of saline diluted three times for approximately 10 s to hemolyze
the erythrocytes. After adding 1000 ml of saline to restore the
osmotic pressure, the solution was centrifuged for 5 min at
2,0006g. After pipetting off the supernatant, the cells were washed
by adding 1000 ml of saline and centrifuged for 5 min at 2,0006g.
After pipetting off the supernatant, 500 ml of fluorescence-
activated cell sorting (FACS) buffer (0.02 M ethylenediaminetet-
raacetic acid and 0.01% bovine serum albumin in PBS) was
added. The purity of GFP+ cells was assessed by FACS (Gallios,
Beckman Coulter, Brea, California).
Neuropathic Pain Model
For the pSNL model of neuropathic pain, surgery was
performed as previously described, with slight modifications
[27,28]. Briefly, under sodium pentobarbital anesthesia, a 5 mm
incision was made and the right sciatic nerve was exposed just
distal to the branch leading to the posterior biceps femoris/
semitendinous muscles. One-third to one-half of the diameter of
the right sciatic nerve at the upper thigh level was ligated tightly
with a 9-0 silk suture. The wound was closed by suturing the
muscle and skin layers.
Behavioral Test
Animals were acclimatized to the testing environment for at
least 1 h before the behavioral test. The same experimenter
handled and tested animals in the experiment and was blinded to
the genotype of each animal. Mechanical sensitivity was assessed
by measuring the paw withdrawal threshold using calibrated von
Frey filaments as previously described, with slight modifications
[29,30]. Mice were acclimatized on a metal mesh floor in small
cylinders for 1 h. Mechanical sensitivity was evaluated using a set
of seven calibrated von Frey filaments (0.008, 0.02, 0.04, 0.07,
0.16, 0.4, and 1.0 g) that were applied to the plantar surface of the
hindpaw until the filament bent slightly for a few seconds. The first
stimulus was always the 0.16 g filament. When a mouse
demonstrated a positive response such as flicking and lifting, the
next lower-weight filament was applied. When a mouse demon-
strated a negative response (i.e., no movement) the next higher-
weight filament was applied. After the first change in response,
four additional responses were observed, and the 50% paw
withdrawal threshold was calculated [29,31].
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Figure 1. Flow cytometry analysis of BM-derived cells in WT/TRPM2-KO BM chimeric mice. Representative histograms of GFP+ cells in WT
mice (A; negative control), GFP-transgenic mice (B; positive control), TRPM2BM+/Rec+ mice (C), TRPM2BM–/Rec+ mice (D), TRPM2BM+/Rec– mice (E), and
TRPM2BM-/Rec– mice (F). In all examined chimeric mice, more than 90% of the BM-derived cells were GFP+.
doi:10.1371/journal.pone.0066410.g001
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Immunohistochemistry
Mice were deeply anesthetized with sodium pentobarbital and
perfused through the ascending aorta with PBS followed by 4%
(W/V) paraformaldehyde in phosphate buffer. The sciatic nerve
was cut 5 mm on either side of the ligation site, and the L3–L5
spinal cord was extirpated from pSNL-induced neuropathic pain
model mice. Then samples were postfixed for 4 h and cryopro-
tected overnight at 4uC in 15% sucrose. The tissues were frozen
and sectioned with a cryostat (Leica, Nussloch, Germany). The
sections (20 mm) were treated with 4% normal goat serum for 1 h
at room temperature. After washing with PBS, the sections were
incubated with a primary antibody directed against Iba-1 (rabbit
anti-Iba-1 antibody, 1:500; Wako Pure Chemical Industries,
Osaka, Japan) at 4uC overnight. The sections were washed three
times in PBS and labeled with fluorescence-labeled secondary
antibody (Alexa Fluor 594-labeled goat anti-rabbit IgG, 1:500;
Molecular Probes, Invitrogen, Life Technologies, Carlsbad, CA) at
room temperature for 1 h in the dark. After washing three times in
PBS, the sections were mounted in the anti-fading medium
Vectashield (Vector Laboratories, Burlingame, CA). Five non-
adjacent sections of the sciatic nerve and the L3–L5 spinal cord
were randomly selected for each animal. Confocal fluorescence
images were observed using a confocal laser scanning microscope
(Fluoview FV10i system, Olympus, Tokyo, Japan). In each section
of the sciatic nerve, a fluorescence image (2006200 mm) was
captured in the area approximately 500 mm distant from the
ligation site. In each section of the spinal cord, a fluorescence
image (3006200 mm) of contralateral and ipsilateral spinal dorsal
horn was captured in the area. Iba1+ and GFP+ cells were counted
in contralateral and ipsilateral regions of interest with Image J
software (National Institute of Mental Health, Bethesda, MD).
Three to six mice were included in each group.
Statistical Analysis
Data are presented as the mean 6 SEM and were analyzed
using GraphPad Prism version 5.0. Statistical analyses of the 50%
withdrawal thresholds were performed using the Kruskal-Wallis
test followed by post hoc Dunn’s comparison test at each time point
and each BM chimeric mouse group, respectively. The numbers of
Iba1+ or GFP+ cells were analyzed by one-way analysis of variance
(ANOVA) followed by post hoc Tukey-Kramer comparison test. In
all cases, differences of p,0.05 were considered statistically
significant.
Results
Neuropathic Pain in BM Chimeric mice
To determine whether TRPM2 expressed in peripheral
immune cells contributes to neuropathic pain, irradiated WT or
TRPM2-KO recipient mice were transplanted with either WT-or
TRPM2-KO donor mouse-derived GFP+ BM cells to generate
four types of BM chimeric mice (TRPM2BM+/Rec+, TRPM2BM–/
Rec+, TRPM2BM+/Rec–, TRPM2BM–/Rec– mice) (see Materials and
Methods for details). Flow cytometric analysis revealed that, 6
weeks after BM transplantation, more than 90% of the BM-
derived cells in the blood of the chimeric mice were replaced with
GFP+ cells (Fig. 1). In TRPM2BM+/Rec+ mice, partial sciatic nerve
ligation (pSNL) surgery significantly decreased the 50% with-
drawal threshold to mechanical stimulation in the ipsilateral paw
(p,0.001, Kruskal-Wallis test). Significant decreases were ob-
served 3, 7 and 14 days after pSNL surgery, compared with pre-
surgery (Day 0). In TRPM2BM–/Rec+, TRPM2BM+/Rec–, and
TRPM2BM–/Rec– mice, pSNL-induced mechanical allodynia was
attenuated. In TRPM2BM–/Rec+ mice, although pSNL surgery
significantly decreased the 50% withdrawal threshold in the
ipsilateral paw (p,0.001, Kruskal-Wallis test), a significant
decrease was observed only 3 days, but not 7 and 14 days, after
pSNL surgery, compared with pre-surgery (Day 0). Compared
with TRPM2BM+/Rec+ mice, pSNL-induced mechanical allodynia
was significantly attenuated on Day 7 and 14. In TRPM2BM+/Rec–
and TRPM2BM–/Rec– mice, pSNL surgery had no effect on the
50% withdrawal threshold in the ipsilateral paw, and no significant
mechanical allodynia was observed during the observed period,
compared with pre-surgery (Day 0). Compared with TRPM2BM+/
Rec+ mice, pSNL-induced mechanical allodynia was significantly
attenuated on Day 3 and 7 in TRPM2BM+/Rec– mice, and on Day
3 in TRPM2BM–/Rec– mice. On the other hand, the 50%
withdrawal thresholds in the contralateral paws were not changed
in any chimeric mice (Fig. 2).
Iba1+ and GFP+ Cells in the Injured Sciatic Nerve in BM
Chimeric mice
Our preliminary data using GFP+ BM chimeric mice showed
that peripheral nerve injury induced infiltration of GFP+ BM-
derived cells in the ipsilateral peripheral nerve, which gradually
increased between Day 3 and 14. On Day 14, the infiltration of
GFP+ BM-derived cells was maximal, and approximately half of
them were Iba1+ macrophages. In this study, we identified Iba1+
and GFP+ cells in the injured sciatic nerve 14 days after pSNL
surgery in TRPM2BM+/Rec+, TRPM2BM–/Rec+, TRPM2BM+/Rec–,
Figure 2. Peripheral nerve injury-induced mechanical allodynia
in WT/TRPM2-KO BM chimeric mice. In the pSNL model of
neuropathic pain, the 50% withdrawal threshold to mechanical stimuli
was determined in the ipsilateral (A) and contralateral paws (B) of
TRPM2BM+/Rec+, TRPM2BM–/Rec+, TRPM2BM+/Rec–, and TRPM2BM+/Rec+ mice.
*p , 0.05; **p , 0.01; ***p , 0.001, compared with TRPM2BM+/Rec+
mice. #p ,0.05; ##p ,0.01, compared with Day 0 in each BM chimeric
mouse group. n= 5–7. Data are expressed as the mean 6 SEM.
doi:10.1371/journal.pone.0066410.g002
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TRPM2BM–/Rec– mice (Fig. 3, Table 1). Small numbers of Iba1+
cells and GFP+ cells were observed in the contralateral sciatic
nerve in all chimeric mice. Some GFP+ cells were double positive
for Iba1. No differences were observed in the number of Iba1+
cells (F3,10 = 0.22, p=0.881) and GFP
+ cells (F3,10 = 0.20,
p=0.896) among chimera groups. Merged images revealed no
difference in the number of Iba1–/GFP+ cells (F3,10 = 0.31,
p=0.816) or Iba1+/GFP+ cells (F3,10 = 0.33, p=0.806) among
chimera groups. Few Iba1+/GFP– cells were observed in any of
the chimera groups, and no difference was observed among
chimera groups (F3,10 = 0.35, p=0.790).
In the ipsilateral sciatic nerve, Iba1+ cells and GFP+ cells were
dramatically increased, and 50–65% of GFP+ cells were positive
for Iba1. Although the number of GFP+ cells tended to increase in
TRPM2BM+/Rec– mice and decrease in TRPM2BM–/Rec– mice, no
significant differences were observed in the numbers of Iba1+ cells
(F3,10 = 0.48, p=0.706) and GFP
+ cells (F3,10 = 2.93, p=0.086)
among chimera groups. Furthermore, merged photographs
revealed no differences in the numbers of Iba1–/GFP+ cells
(F3,10 = 1.43, p=0.292) or Iba1
+/GFP+ cells (F3,10 = 0.53,
p=0.670) among chimera groups. The number of Iba1+/GFP–
cells was low in all chimera groups, and no difference was observed
among chimera groups (F3,10 = 2.21, p=0.150).
Figure 3. Infiltration of GFP+ BM-derived cells around the injured sciatic nerve in WT/TRPM2-KO BM chimeric mice. (A) GFP+ cells and
Iba1+ cells were visualized by GFP fluorescence (green) and immunostaining with Iba1 antibody (red), respectively, in the sciatic nerve sections
around the ligation site 14 days after pSNL surgery. Iba1+/GFP+ cells were visualized as a yellow signal in merged images. Representative
microphotographs are shown (scale bars = 50 mm). (B) The numbers of Iba12/GFP+ cells, Iba1+/GFP2cells, and Iba1+/GFP+ cells within the images
were counted in the contralateral (left panel) and ipsilateral (right panel) sections. n= 3–5. Data are expressed as the mean 6 SEM.
doi:10.1371/journal.pone.0066410.g003
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Iba1+ and GFP+ Cells in the Spinal Dorsal Horn in
Chimeric mice
Our preliminary data using GFP+ BM chimeric mice showed
that peripheral nerve injury induced infiltration of GFP+ BM-
derived cells into the ipsilateral spinal dorsal horn, which peaked
between Day 7 and 14. Other previous findings have also shown
that spinal infiltration of peripheral immune cells is maximal
between 7 and 21 days after the peripheral nerve injury [4,6,8]. In
this study, we identified Iba1+ cells and GFP+ cells in the spinal
dorsal horn 14 days after pSNL surgery in TRPM2BM+/Rec+,
TRPM2BM–/Rec+, TRPM2BM+/Rec–, TRPM2BM–/Rec– mice
(Fig. 4, Table 2). In the contralateral dorsal horn, a few Iba1+
cells were observed, but there were no or few GFP+ cells or Iba1+/
GFP+ cells in any of the chimeric mice. No differences were
observed in the numbers of Iba1+ cells (F3,13 = 0.07, p=0.976) and
GFP+ cells (F3,13 = 1.08, p=0.392). Merged photographs revealed
that no differences in the numbers of Iba1+/GFP– cells
(F3,13 = 0.11, p=0.954), Iba1
–/GFP+ cells (F3,13 = 0.52, p=0.677)
and Iba1+/GFP+ cells (F3,13 = 0.58, p=0.640) among chimera
groups.
The number of Iba1+ cells and GFP+ cells dramatically
increased in the ipsilateral dorsal horn, and 50–95% of GFP+
cells were double positive for Iba1. The number of Iba1+ cells
decreased in TRPM2BM–/Rec+, TRPM2BM+/Rec–, and
TRPM2BM–/Rec– mice compared with that in TRPM2BM+/Rec+
mice, although no statistical difference was observed (F3,13 = 2.52,
p=0.104). Similarly, the number of GFP+ cells decreased in
TRPM2BM–/Rec+, TRPM2BM+/Rec– and TRPM2BM–/Rec– mice,
compared with that in TRPM2BM+/Rec+ mice, although no
statistical difference was observed (F3,13 = 2.92, p=0.074). Merged
photographs revealed that the number of Iba1+/GFP+ cells
significantly decreased in chimeric mice (F3,13 = 6.73, p,0.01).
Significant decreases were observed in TRPM2BM–/Rec+,
TRPM2BM+/Rec–, and TRPM2BM–/Rec– mice compared with
TRPM2BM+/Rec+ chimeric mice. However, no difference was
observed in the numbers of Iba1+/GFP– cells (F3,13 = 0.58,
p=0.641) or Iba1–/GFP+ cells (F3,13 = 0.25, p=0.857) among
chimera groups.
Discussion
The results of the present study showed that pSNL-induced
mechanical allodynia was attenuated by TRPM2 deficiency in
either donor BM cells or recipient mice, similarly to that in
TRPM2BM–/Rec– mice. TRPM2 deficiency in either the donor
BM cells or recipient mice led to reduced infiltration of GFP+
peripheral immune cells (particularly Iba1+ macrophages) into the
dorsal horn. However, neither the infiltration of GFP+ peripheral
immune cells (including Iba1+ macrophages) into the sciatic nerve,
nor the number of Iba1+/GFP– resident microglia in the spinal
dorsal horn, were affected 14 days after pSNL surgery. These
findings suggest that TRPM2 expressed not only in peripheral
immune cells but also other cells such as spinal microglia plays an
important role in the spinal infiltration of macrophages following
peripheral nerve injury, which may contribute to neuropathic
pain.
Our previous report [24] shows that TRPM2 deficiency reduces
peripheral nerve injury-induced production of CXCL2, the most
potent chemoattractant for neutrophils, which is produced by
monocytes/macrophages [32–34], and that infiltration of neutro-
phils, but not macrophages, into the injured sciatic nerve.
Furthermore, mechanical allodynia evoked by intraplantar injec-
tion of lipopolysaccharide (LPS)-stimulated macrophages was
weak in TRPM2-KO-derived macrophages. However, these
TRPM2-mediated responses of macrophages, i.e. CXCL2 pro-
duction and neutrophil infiltration, in the injured sciatic nerve
were partial, and restricted to the early phase of neuropathic pain
(within 1 day). By contrast, the activation of spinal Iba1-or OX42-
positive cells (referred to as microglia in the previous report) was
suppressed in TRPM2-KO mice throughout the period of
neuropathic pain. Therefore, although both peripheral macro-
phages and spinal microglia could be involved in neuropathic
pain, it is possible that the prolonged inhibition of spinal microglia
caused by TRPM2 deficiency may largely contribute to the
prevention of neuropathic pain. This hypothesis is consistent with
the present results, in which TRPM2BM+/Rec– mice showed less
pSNL-induced mechanical allodynia. However, the present data
also showed that mechanical allodynia was attenuated in
TRPM2BM–/Rec+ mice, suggesting the involvement of TRPM2
expressed by BM-derived peripheral immune cells including
macrophages in neuropathic pain.
In the present chimeric mice, a large number of GFP+
peripheral immune cells were observed in the injured sciatic
nerve, and more than half of them were Iba1+ macrophages.
Consistent with our previous report [24], the number of Iba1+/
GFP+ macrophages was not changed in any on the TRPM2-KO
chimeric mice 14 days after pSNL surgery, suggesting that
TRPM2 is not involved in the chemotactic activity of macro-
phages directed to the injured site. Additionally, the chimeric mice
showed no effect on the infiltration of Iba1–/GFP+ peripheral
immune cells other than macrophages, which may include
neutrophils. Our previous report showed that TRPM2 deficiency
Table 1. The numbers of Iba1+ and GFP+ cells around the injured sciatic nerve.
Contralateral Ipsilateral
TRPM2BM+/Rec+ TRPM2BM–/Rec+ TRPM2BM+/Rec– TRPM2BM–/Rec– TRPM2BM+/Rec+ TRPM2BM–/Rec+ TRPM2BM+/Rec– TRPM2BM–/Rec–
Total cells 3.7 6 0.7 4.3 6 1.3 3.0 6 0.6 3.4 6 0.8 24.7 6 7.3 25.0 6 0.6 32.0 6 4.6 20.6 6 3.0
Iba1+ cells 0.7 6 0.3 1.3 6 0.6 1.0 6 0.6 1.2 6 0.6 18.7 6 7.3 15.7 6 3.7 17.0 6 6.1 11.2 6 3.6
GFP+ cells 3.3 6 0.9 4.0 6 1.5 3.0 6 0.6 3.2 6 0.7 18.7 6 4.3 23.3 6 1.8 32.0 6 4.6 19.6 6 2.8
Iba1–/GFP+ cells 3.0 6 0.6 3.0 6 1.2 2.0 6 0.6 2.2 6 0.9 6.0 6 2.0 9.3 6 3.7 15.0 6 2.5 9.4 6 2.7
Iba1+/GFP– cells 0.3 6 0.3 0.3 6 0.3 0 0.2 6 0.2 6.0 6 3.2 1.7 6 1.7 0 1.0 6 1.0
Iba1+/GFP+ cells 0.3 6 0.3 1.0 6 0.6 1.0 6 0.6 1.0 6 0.5 12.7 6 4.1 14.0 6 2.0 17.0 6 6.1 10.2 6 3.3
The numbers of Iba1+ cells, GFP+ cells, Iba1+/GFP– cells, Iba1–/GFP+ cells, and Iba1+/GFP+ cells were counted in the contralateral and ipsilateral sciatic nerve 14 days after
pSNL surgery. ‘‘Total cells’’ indicates the sum of Iba1+/GFP– cells, Iba1–/GFP+ cells, and Iba1+/GFP+ cells. n= 3–5. Data are expressed as mean 6 SEM.
doi:10.1371/journal.pone.0066410.t001
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reduced the infiltration of neutrophils into the injured sciatic nerve
[24], probably due to decreased CXCL2 production by the
resident and recruited macrophages. However, the peak time of
the neutrophil infiltration was 1 day, and a low number of
neutrophils were observed 14 days after pSNL surgery. Because
the reduction of neutrophil infiltration by TRPM2 deficiency was
observed only 8 h after pSNL surgery [24], it is possible that the
reduction was not detected at 14 days after the surgery in the
present study, although it has not been determined whether
Iba1–/GFP+ peripheral immune cells, particularly Gr-1+ neutro-
phils, are reduced in TRPM2-KO BM chimeric mice 8 h after
pSNL surgery.
Figure 4. Infiltration of GFP+ BM-derived cells into the spinal cord in WT/TRPM2-KO BM chimeric mice. (A, B) GFP+ cells and Iba1+ cells
were visualized by GFP fluorescence (green) and immunostaining with Iba1 antibody (red), respectively, in the spinal cord sections 14 days after pSNL
surgery. Iba1+/GFP+ cells were visualized as a yellow signal in merged images. (A) Representative microphotographs in WT-BM and WT chimeric mice
are shown (scale bars = 200 mm). (B) Representative microphotographs in selected regions of contralateral and ipsilateral spinal dorsal horn (defined
by the rectangular area in A) are shown (scale bars = 100 mm). (C) The numbers of Iba1-/GFP+ cells, Iba1+/GFP-cells, and Iba1+/GFP+ cells within the
selected regions were counted in the contralateral (left panel) and ipsilateral (right panel) spinal dorsal horn. n=3–6. Data are expressed as the mean
6 SEM.
doi:10.1371/journal.pone.0066410.g004
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By contrast, the number of Iba1+ cells in the spinal dorsal horn
tended to decrease in all TRPM2-KO chimeric mice 14 days after
pSNL surgery. However, the number of GFP–/Iba1+ cells,
representing spinal-resident microglia, was not changed in any
TRPM2-KO chimeric mice. These findings suggest that the
increased number of Iba1+ cells in the spinal dorsal horn is mainly
due to the increase in the spinal infiltration of Iba1+ macrophages,
and that TRPM2 plays no role in the increased number of spinal-
resident microglia, at least at 14 days after pSNL surgery. Notably,
the increased number of GFP–/Iba1+ resident microglia represents
an increase in microglial proliferation and/or chemotaxis from
other regions, rather than microglial activation. The activation of
spinal microglia (represented by an increase in Iba1 immunore-
activity and morphological changes to activation state) peaks at 3
days and declines within 2 weeks after pSNL surgery [24], while
spinal infiltration of peripheral immune cells is delayed following
the activation of spinal-resident microglia. Spinal infiltration by
peripheral immune cells starts at 3 days and peaks at 14 days after
peripheral nerve injury [6,35]. Our previous report demonstrated
that TRPM2 plays a critical role in the initial activation of spinal-
resident microglia [24].
The present results showed that the number of GFP+ cells in the
spinal dorsal horn, which represent infiltrated peripheral immune
cells, tended to decrease in all TRPM2 chimeric mice. Further-
more, most infiltrated GFP+ peripheral immune cells are Iba1+
macrophages, which were markedly decreased in TRPM2
chimeric mice. Consistent with the present results, recent evidence
suggests that peripheral nerve injury induces the infiltration of
peripheral immune cells into the spinal cord [4–8]. The blood-
spinal cord barrier (BSCB) constitutes a physical and biochemical
barrier between the spinal cord and the peripheral circulation.
Peripheral nerve injury triggers the leakage of the BSCB through
spinal inflammatory responses, resulting the influx of inflamma-
tory mediators and the infiltration of peripheral immune cells
[35,36]. Because spinally-infiltrated macrophages were differenti-
ated as fully functional microglia, activation of both spinally-
infiltrated macrophages and spinal-resident microglia contributes
to the induction and persistence of neuropathic pain [6]. Taken
together, these results suggest that inhibition of neuropathic pain
observed in TRPM2-KO chimeric mice is due to the reduction of
TRPM2-mediated spinal infiltration of macrophages, as well as
activation of spinal-resident microglia. When using BM chimeric
mice to study conditions of the central nervous system (CNS),
some limitations should be considered. Whole-body irradiation has
been reported to have direct consequences on the CNS, such as
disruption of the blood-brain barrier [37]. Although we cannot
ignore the effect of irradiation, an indisputable body of evidence
suggests that disruption of BSCB and spinal infiltration of
peripheral immune cells clearly occurs following peripheral nerve
injury even in non-irradiated animals [5,7,8,35,38].
The mechanism underlying TRPM2-mediated spinal infiltra-
tion of macrophages is still unknown. As described above, TRPM2
plays no role in the chemotactic activity of macrophages. By
contrast, TRPM2 deficiency attenuates peripheral nerve injury-
induced activation of resident microglia, which precedes the spinal
infiltration of macrophages. Consequently, TRPM2 deficiency
may conceivably attenuate the initial deterioration of the spinal
microenvironment by activating spinal-resident microglia, result-
ing in protection against disruption of the BSCB. However,
leakage of the BSCB is not affected by intrathecal injection of
minocycline, a microglial inhibitor, suggesting that BSCB disrup-
tion is independent of the activation of spinal-resident microglia
[35]. Further investigations will be needed to elucidate the
mechanisms.
Conclusions
In summary, the present study revealed that TRPM2 expressed
in peripheral immune cells and/or other cells plays a role in the
spinal infiltration of macrophages, rather than infiltration of
peripheral immune cells into the injured nerves and activation of
spinal-resident microglia by using a set of WT/TRPM2-KO BM
chimeric mice. Furthermore, the spinal infiltration of macrophages
mediated through TRPM2 is suggested to contribute to the
induction and persistence of neuropathic pain. The present
findings provide evidence for a role of TRPM2 in neuropathic
pain, suggesting that TRPM2 might be a promising target for the
treatment of neuropathic pain.
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